(firstQuint)Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study.

 This study will enroll total 30 patients with medically intractable epilepsy.

 The patients will be fully assessed on the enrollment, and then seizure frequency will be counted for three months without changing medication.

 After three months, Omega-3 will be administered for next three months.

 Seizure frequency, questionnaires evaluating mood and QOL, and adverse events are evaluated at each visit.

.

 Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study@highlight

The purpose of this study is to determine whether omega-3 is effective in the treatment of medically intractable epilepsy as adjunctive therapy.

